Atlas Trials

Adjuvant Immunotherapy After Salvage Surgery in Head and Neck Squamous Cell Carcinoma

Clinical trial NCT03406247 · RECRUITING

Trial details

NCT number
NCT03406247
Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Head and Neck Squamous Cell Carcinoma
Start date
2018-02-12
Primary completion
2027-11-01
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.